Strategies for investigating the maternal-fetal interface in the first trimester of pregnancy: What can we learn about pathology?, Placenta. déc, vol.60, pp.145-154, 2017. ,
Consensus d'experts HTA et Grossesse de la SFHTA, 2015. ,
Prise en charge du HELLP syndrome ,
Les facteurs influençant la décision de voie d'accouchement entre 26 et 32 SA et 6 jours, 2013. ,
Prématurité modérée 34-37SA : description des causes et conséquences néonatales immédiates dans une maternité de niveau 2, Gynécologie Obstétrique Fertil. sept, vol.43, issue.9, pp.582-589, 2015. ,
, Collège National des Gynécologues et Obstétriciens Français, J Gynécologie Obstétrique Biol Reprod. sept, vol.34, issue.5, p.513, 2005.
, , 2016.
Risk factors for low birth weight and preterm birth: A population-based case-control study in Wuhan, China. J Huazhong Univ Sci Technol Med Sci, vol.37, issue.2, pp.286-92, 2017. ,
Morts maternelles par complications hypertensives. Résultats de l'enquête confidentielle française sur la mortalité maternelle, Gynécologie Obstétrique Fertil Sénologie. déc, vol.45, issue.12, pp.38-42, 2017. ,
Outcomes in Young Adulthood for Very-Low-Birth-Weight Infants, N Engl J Med, vol.9, 2002. ,
DOHaD : conséquences à long terme de la pathologie périnatale: Retard de croissance intra-utérin et prématurité. médecine/sciences, janv, vol.32, issue.1, pp.74-80, 2016. ,
Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia, Am J Obstet Gynecol. 1 sept, vol.155, issue.3, pp.501-508, 1986. ,
Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am J Obstet Gynecol, vol.169, issue.4, pp.1000-1006, 1993. ,
Hypertensive disorders in twin pregnancy, Eur J Obstet Gynecol Reprod Biol. janv, vol.58, issue.1, pp.9-13, 1995. ,
Poor effectiveness of antenatal detection of fetal growth restriction and consequences for obstetric management and neonatal outcomes: a French national study, BJOG Int J Obstet Gynaecol, vol.122, issue.4, pp.518-545, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02008032
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia, N Engl J Med. 17 août, vol.377, issue.7, pp.613-635, 2017. ,
Prise en charge multidisciplinaire des formes graves de prééclampsie ,
A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction, vol.11, 2016. ,
Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study, J Matern Fetal Neonatal Med. 17 janv, vol.32, issue.2, pp.248-57, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-01800200
on behalf of the Spanish Group for the Study of Angiogenic Markers in Preeclampsia. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/ PlGF Ratio in Singleton Pregnancies, Fetal Diagn Ther, vol.43, issue.2, pp.81-90, 2018. ,
, Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis. Int J Mol Sci. 23 sept, vol.16, issue.9, pp.23035-56, 2015.
Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years, Eur J Obstet Gynecol Reprod Biol. mars, vol.95, issue.1, pp.59-67, 2001. ,
Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia, J Matern Fetal Neonatal Med. 19 mars, vol.30, issue.6, pp.635-644, 2017. ,
Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenat Diagn, vol.37, issue.3, pp.253-65, 2017. ,
, Interprétation des valeurs atypiques des marqueurs sériques, J Gynécologie Obstétrique Biol Reprod. 1 janv, vol.43, issue.1, pp.5-11, 2014.
Fetal major cardiac defects and placental dysfunction at 11-13 weeks' gestation, Ultrasound Obstet Gynecol. 1 févr, vol.51, issue.2, pp.194-202, 2018. ,
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation, Ultrasound Obstet Gynecol, vol.52, issue.2, pp.186-95, 2018. ,
Placental expression of PAPPA, PAPPA-2 and PLAC-1 in pregnacies is associated with FGR, Mol Med Rep. mai, vol.17, issue.5, pp.6435-6475, 2018. ,
First trimester maternal serum analytes and second trimester uterine artery Doppler in the prediction of preeclampsia and fetal growth restriction, Taiwan J Obstet Gynecol. juin, vol.56, issue.3, pp.358-61, 2017. ,
Biological functions of hCG and hCG-related molecules, Reprod Biol Endocrinol RBE. 24 août, vol.8, p.102, 2010. ,
Associations between maternal serum free beta human chorionic gonadotropin (?-hCG) levels and adverse pregnancy outcomes, J Obstet Gynaecol. 17 févr, vol.36, issue.2, pp.178-82, 2016. ,
First trimester hyperglycosylated human chorionic gonadotrophin in serum -A marker of early-onset preeclampsia, Placenta, vol.34, issue.11, pp.1059-65, 2013. ,
ASPRE trial: performance of screening for preterm pre-eclampsia, Ultrasound Obstet Gynecol, vol.50, issue.4, pp.492-497, 2017. ,
Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11-13 Weeks, Fetal Diagn Ther, vol.29, issue.2, pp.148-54, 2011. ,
Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates, Prenat Diagn, vol.31, issue.1, pp.58-65, 2011. ,
Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers, Adv Clin Exp Med Off Organ Wroclaw Med Univ. juin, vol.26, issue.3, pp.439-487, 2017. ,
New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia With Fetal Growth Restriction, Reprod Sci. 1 mai, vol.24, issue.5, pp.783-792, 2017. ,
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies, Placenta. mai, vol.36, issue.5, pp.538-582, 2015. ,
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE, Ultrasound Obstet Gynecol, vol.52, issue.1, pp.52-61, 2018. ,
Early Prediction of Preeclampsia, Obstetrics and Gynecology International, 2014. ,
Aspirine : indications et utilisation durant la grossesse, Rev Médecine Interne. déc, vol.38, issue.12, pp.825-857, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01659441
Définitions : petit poids pour l'âge gestationnel et retard de croissance intrautérin, J Gynécologie Obstétrique Biol Reprod, vol.42, issue.8, pp.872-94, 2013. ,
Building consensus and standards in fetal growth restriction studies, Best Pract Res Clin Obstet Gynaecol. mai, vol.49, pp.117-143, 2018. ,
An integrated approach to fetal growth restriction, Best Pract Res Clin Obstet Gynaecol. janv, vol.38, pp.48-58, 2017. ,
Parental Age and the Risk of Gestational Hypertension and Preeclampsia, Southern Medical Journal. Septembre, vol.111, pp.544-548, 2018. ,
Maternal Age and Risk of Labor and Delivery Complications, Matern Child Health J. 1 juin, vol.19, issue.6, pp.1202-1213, 2015. ,
Cigarette smoking during pregnancy and preeclampsia risk: a systematic review and meta-analysis of prospective studies, Oncotarget, vol.6, issue.41, pp.43667-78, 2015. ,
Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort, Ann Med, vol.49, issue.7, pp.593-602, 2017. ,
A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis, PLoS ONE. Fevrier, vol.12, issue.2, 2017. ,
Early Pregnancy Levels of Pregnancy-Associated Plasma Protein A and the Risk of Intrauterine Growth Restriction, Premature Birth, Preeclampsia, and Stillbirth ,
Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis, Prenat Diagn, vol.37, issue.3, pp.253-65, 2017. ,
Screening for adverse pregnancy outcome at early gestational age, Clin Chim Acta, pp.1547-52, 2010. ,
Circulating Angiogenic Factors and the Risk of Preeclampsia, N Engl J Med, vol.12, 2004. ,
The effect of low-dose aspirin on serum placental growth factor levels in a high-risk PREDO cohort, Pregnancy Hypertens. juill, vol.13, pp.51-58, 2018. ,